\n \n \n “. concat(self. i18n. t(‘search. voice. recognition_retry’), “\n
” s ” ” t. config. saAria. shownText “
“e. config. saAria. closedText”
Summary: What’s new for 2022? Global competitiveness and market share as a percentage of major competitors. Market presence in geographical areas – Strong/Active/Niche/Trivial.
New York, Oct. 05, 2022 (GLOBE NEWSWIRE) — Reportlinker. com Announces Release of “Global COVID-19 Vaccines Industry” Report – https://www. reportlinker. com/p06097782/?utm_source=GNW Interactive Online Bespoke peer-to-peer collaborative updatesAccess to our virtual archives and MarketGlass research platformFree updates for one year: Global COVID-19 vaccine market to reach $60. 7 billion by 2025: Annual COVID-19 vaccine doses estimated in US $255 million in 2020, projected to hit $60. 7 billion through 2025. The value of annual doses in China is forecast to stabilize at $23 billion through 2025, after peaking at $73 billion million in 2021. The global percentage of Americans vaccinated through 2025 is expected to decline to 47% through 2025 from an estimated 73% by 2022. – The vaccinated population e n Africa will be successful at only 12% through 2023, a figure that will drop to 4% through 2025. By comparison, the percentage of Americans vaccinated in France is expected to reach 92% through the end of 2022. number of doses administered globally to increase to 4. 186 billion by 2025. Selected Competitors (total 358 featured)Moderna, Inc. Pfizer Inc. /BioNTechAstraZeneca/Oxford Johnson University